Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar
View ORCID ProfileHiam Chemaitelly, View ORCID ProfileHoussein H. Ayoub, View ORCID ProfileSawsan AlMukdad, View ORCID ProfilePatrick Tang, View ORCID ProfileMohammad R. Hasan, View ORCID ProfileHadi M. Yassine, View ORCID ProfileHebah A. Al Khatib, Maria K. Smatti, View ORCID ProfilePeter Coyle, View ORCID ProfileZaina Al Kanaani, Einas Al Kuwari, View ORCID ProfileAndrew Jeremijenko, View ORCID ProfileAnvar Hassan Kaleeckal, Ali Nizar Latif, View ORCID ProfileRiyazuddin Mohammad Shaik, View ORCID ProfileHanan F. Abdul Rahim, View ORCID ProfileGheyath K. Nasrallah, View ORCID ProfileMohamed Ghaith Al Kuwari, Adeel A. Butt, View ORCID ProfileHamad Eid Al Romaihi, View ORCID ProfileMohamed H. Al-Thani, Abdullatif Al Khal, View ORCID ProfileRoberto Bertollini, View ORCID ProfileLaith J. Abu-Raddad
doi: https://doi.org/10.1101/2022.02.07.22270568
Hiam Chemaitelly
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
PhDHoussein H. Ayoub
4Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar
PhDSawsan AlMukdad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
MScPatrick Tang
5Department of Pathology, Sidra Medicine, Doha, Qatar
MD PhDMohammad R. Hasan
5Department of Pathology, Sidra Medicine, Doha, Qatar
PhDHadi M. Yassine
6Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
7Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhDHebah A. Al Khatib
6Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
7Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhDMaria K. Smatti
6Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
7Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
MScPeter Coyle
6Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
8Hamad Medical Corporation, Doha, Qatar
9Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom
MDZaina Al Kanaani
8Hamad Medical Corporation, Doha, Qatar
PhDEinas Al Kuwari
8Hamad Medical Corporation, Doha, Qatar
MDAndrew Jeremijenko
8Hamad Medical Corporation, Doha, Qatar
MDAnvar Hassan Kaleeckal
8Hamad Medical Corporation, Doha, Qatar
MScAli Nizar Latif
8Hamad Medical Corporation, Doha, Qatar
MDRiyazuddin Mohammad Shaik
8Hamad Medical Corporation, Doha, Qatar
MScHanan F. Abdul Rahim
10Department of Public Health, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhDGheyath K. Nasrallah
6Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
7Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhDMohamed Ghaith Al Kuwari
11Primary Health Care Corporation, Doha, Qatar
MDAdeel A. Butt
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
8Hamad Medical Corporation, Doha, Qatar
12Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, USA
MBBS MSHamad Eid Al Romaihi
13Ministry of Public Health, Doha, Qatar
MDMohamed H. Al-Thani
13Ministry of Public Health, Doha, Qatar
MDAbdullatif Al Khal
8Hamad Medical Corporation, Doha, Qatar
MDRoberto Bertollini
13Ministry of Public Health, Doha, Qatar
MD MPHLaith J. Abu-Raddad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
10Department of Public Health, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhD
Article usage
Posted February 08, 2022.
Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Patrick Tang, Mohammad R. Hasan, Hadi M. Yassine, Hebah A. Al Khatib, Maria K. Smatti, Peter Coyle, Zaina Al Kanaani, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al Kuwari, Adeel A. Butt, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2022.02.07.22270568; doi: https://doi.org/10.1101/2022.02.07.22270568
Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Patrick Tang, Mohammad R. Hasan, Hadi M. Yassine, Hebah A. Al Khatib, Maria K. Smatti, Peter Coyle, Zaina Al Kanaani, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al Kuwari, Adeel A. Butt, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2022.02.07.22270568; doi: https://doi.org/10.1101/2022.02.07.22270568
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)